🇺🇸 FDA
Pipeline program

CEA-targeted CAR-T cells

PBC055

Phase 2 mab active

Quick answer

CEA-targeted CAR-T cells for Gastric Cancer is a Phase 2 program (mab) at PRECISION BIOSCIENCES INC with 3 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Gastric Cancer
Phase
Phase 2
Modality
mab
Status
active

Clinical trials